Omalizumab (omalizumab for subcutaneous use) [package insert]. South San Francisco (CA): Genentech, Inc., 2006 US Food and Drug Administration. Center for Drug Evaluation and Research. Omalizumab (marketed as Xolair) information [online]. Available from URL: http://www.fda.gov/cder/drug/info...